AMPH Amphastar Pharmaceuticals, Inc.

15.56
+0.02  (0%)
Previous Close 15.54
Open 15.59
Price To book 2.19
Market Cap 711.67M
Shares 45,737,000
Volume 175,010
Short Ratio 5.30
Av. Daily Volume 333,921

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Albuterol DPI
Asthma
CRL announced February 21, 2017.
Naloxone Intranasal
Opioid overdose
CRL issued December 27, 2016.
Primatene Mist (epinephrine inhalation aerosol)
Asthma

Latest News

  1. Edited Transcript of AMPH earnings conference call or presentation 8-May-17 9:00pm GMT
  2. Amphastar Pharmaceuticals to Present at the 20th Annual Bank of America Merrill Lynch Health Care Conference
  3. Amphastar beats 1Q profit forecasts
  4. Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2017
  5. Investor Network: Amphastar Pharmaceuticals, Inc. to Host Earnings Call
  6. Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2017
  7. Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on May 8, 2017
  8. Amphastar Pharmaceuticals, Inc. – Value Analysis (NASDAQ:AMPH) : April 26, 2017
  9. Amphastar Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : AMPH-US : April 25, 2017
  10. Amphastar Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference
  11. Blog Coverage Sonoma Pharmaceuticals Announced FDA Clearance for Loyon Skin Descaler
  12. ETFs with exposure to Amphastar Pharmaceuticals, Inc. : March 27, 2017
  13. Amphastar Pharmaceuticals, Inc. :AMPH-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017
  14. Edited Transcript of AMPH earnings conference call or presentation 13-Mar-17 9:00pm GMT
  15. Amphastar reports 4Q loss
  16. Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2016
  17. Williams-Sonoma Among 5 Earnings Plays That Could Squeeze the Shorts
  18. Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 13, 2017